Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10 …

JT Lin, XM Li, WZ Zhong, QY Hou, CL Liu… - Annals of Nuclear …, 2024 - Springer
Objectives To elucidate the impact of [18F] FDG positron emission tomography/computed
tomography (PET/CT) vs. CT workup on staging and prognostic evaluation of clinical stage …

Staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)

S Tönnies, TT Bauer, D Misch, C Boch… - Pneumologie …, 2012 - europepmc.org
Background PET/CT investigation with 18F-fluorodeoxyglucose (FDG) has a high sensitivity
(89-100%) and good specificity (79-95%) for the diagnosis of NSCLC. Currently, it is mainly …

Use of Preoperative FDG PET/CT and Survival of Patients with Resectable Non–Small Cell Lung Cancer

WM Chen, M Chen, JG Hsu, TS Lee, BC Shia, SY Wu - Radiology, 2022 - pubs.rsna.org
Background The added value of preoperative PET/CT for the overall survival of patients with
resectable non–small cell lung cancer (NSCLC) is unknown. Purpose To investigate the …

A randomized controlled trial (RCT) of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus conventional imaging (CI) in staging potentially …

D Maziak, GE Darling, RI Inculet… - Journal of Clinical …, 2008 - ascopubs.org
7502 Background: Patients with early-stage NSCLC who undergo surgery have the highest
survival among patients with NSCLC. Preoperative imaging tests are critical in defining …

Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer

S Takeuchi, B Khiewvan, PS Fox, SG Swisher… - European journal of …, 2014 - Springer
Purpose Our objective was to determine the impact of initial 18 F-FDG PET/CT (PET/CT)
staging on clinical stage and the management plan and the prognostic value of PET/CT in …

Consistency and prognostic value of preoperative staging and postoperative pathological staging using18F-FDG PET/MRI in patients with non-small cell lung cancer

A Kajiyama, K Ito, H Watanabe, S Mizumura… - Annals of Nuclear …, 2022 - Springer
Objective In recent years, positron emission tomography/magnetic resonance imaging
(PET/MRI) has been clinically used as a method to diagnose non-small cell lung cancer …

Diagnostic effectiveness, cost-effectiveness and prognostic utility of PET/CT in non-small cell lung cancer (NSCLC)

A Buck, K Herrmann, J Schreyogg, G Glatting… - 2008 - Soc Nuclear Med
160 Objectives: The aim of this prospective bi-center trial was to evaluate the diagnostic
accuracy, prognostic potential and cost effectiveness of PET/CT for staging NSCLC …

[PDF][PDF] 18F-FDG PET/contrast-enhanced CT for initial staging and strategic treatment of non-small cell lung cancer: a prospective study

C Promteangtrong, A Kunawudhi, R Phadungrerk… - J Med Assoc …, 2015 - thaiscience.info
Background: Selection of the best treatment option for non-small cell lung cancer (NSCLC)
depends on optimal initial staging. Objective: Evaluate the clinical impact of 18F-FDG …

[HTML][HTML] Role of 18F-FDG PET/CT in the postoperative follow-up in patients with stage I-III NSCLC: A retrospective single-institution study

A Kaumanns, D König, A Hojski, M Cattaneo… - Lung Cancer, 2022 - Elsevier
Background The optimal surveillance strategy in patients with resected non-small cell lung
cancer (NSCLC) is unknown. Early detection of recurrences by follow-up imaging might …

[PDF][PDF] Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer

N Ceylan, S Dogan, K Kocaçelebi… - Diagnostic and …, 2012 - researchgate.net
PURPOSE The purpose of this study was to retrospectively evaluate the effectiveness of
integrated positron emission tomographycomputed tomography (PET-CT) in comparison …